Close Menu

NEW YORK (GenomeWeb) - Chembio Diagnostic Systems announced today that it has received a $550,000 grant from the Paul G. Allen Family Foundation to develop point-of-care diagnostics for the Zika virus.

Medford, New York-based Chembio will use the grant to develop a Zika-specific assay for  its Dual Path Platform (DPP) technology, as well as a multiplex assay to detect the Zika, Dengue, and Chikungunya viruses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.